Register entry
- Registered sites
- 0
- Active NDC listings
- 3
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
33 active NDC listings: 3 vaccine. By marketing category: DRUG FOR FURTHER PROCESSING 3.
| Dosage form | NDCs |
|---|---|
| injection, suspension | 2 |
| suspension | 1 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| alloga logstica espaa s.l. | 3 |
Catalogue
Marketed products
3| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | CX-038839 OMICRON (XBB.1.5) | injection, suspension | 84586-001DRUG FOR FURTHER PROCESSING |
| - | Moderna COVID-19 Vaccine | injection, suspension | 84586-012DRUG FOR FURTHER PROCESSING |
| - | Respiratory Syncytial Virus Vaccine | suspension | 84586-112DRUG FOR FURTHER PROCESSING |
Compare
Other companies listing cx-038839 omicron (xbb.1.5)
- ROVI Pharma Industrial Services S.A.4 sites · 16 NDC
Enquiry
Common questions
- Is Alloga Logstica Espaa S.L. FDA approved?
- Alloga Logstica Espaa S.L. holds no registered establishment of its own; 3 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Alloga Logstica Espaa S.L. make?
- 3 products are listed under Alloga Logstica Espaa S.L. in the openFDA NDC Directory, most often as injection, suspension; suspension. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.